Close Asset Management’s MaxCyte MXCT Stock Holding History

Close Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3K	Hold	4,000	–	–	﹤0.01%	251
2025 Q4	$6K	Hold	4,000	–	–	﹤0.01%	241
2025 Q3	$6K	Sell	4,000 -3,800	-49%	-$6.6K	﹤0.01%	242
2025 Q2	$17K	Buy	7,800 +4,000	+105%	+$9.69K	﹤0.01%	205
2025 Q1	$10K	Hold	3,800	–	–	﹤0.01%	216
2024 Q4	$16K	Hold	3,800	–	–	﹤0.01%	202
2024 Q3	$15K	Hold	3,800	–	–	﹤0.01%	212
2024 Q2	$15K	Hold	3,800	–	–	﹤0.01%	209
2024 Q1	$16K	Hold	3,800	–	–	﹤0.01%	206
2023 Q4	$18K	Hold	3,800	–	–	﹤0.01%	187
2023 Q3	$12K	Sell	3,800 -19,000	-83%	-$76.4K	﹤0.01%	195
2023 Q2	$105K	Hold	22,800	–	–	﹤0.01%	130
2023 Q1	$113K	Buy	+22,800	New	+$112K	0.01%	120

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Close Asset Management's MXCT Position: Q1 2026 in Review

Close Asset Management held its MaxCyte (MXCT) position steady in Q1 2026 at 4,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

Close Asset Management first reported a position in MXCT in Q1 2023 and has held it in 13 quarters since. The position peaked at $113K in Q1 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Close Asset Management held 4,000 shares of MaxCyte worth $3K as of Q1 2026.
Close Asset Management left its MaxCyte share count unchanged in Q1 2026.
MaxCyte made up ﹤0.01% of Close Asset Management's portfolio in Q1 2026, its #251 holding.
Close Asset Management first reported a position in MaxCyte in Q1 2023 and has held it in 13 quarters since.
Close Asset Management's MaxCyte position peaked at $113K in Q1 2023.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.